Eric Benevich - Chief Commercial Officer, Neurocrine Biosciences Inc

As of August 18, 2021


Eric Benevich Net Worth

  • Net worth is estimated to be at least $9.49M
  • Owns at least 15,608 units of Neurocrine Biosciences Inc stock
  • Sold an estimated value of $7.87M in the last 6 years at Neurocrine Biosciences Inc

Eric Benevich Compensation at Neurocrine Biosciences Inc in 2018

  • Earned a $432,600 salary and a $205 bonus
  • Rewarded $1,499,417 in stock value and options
  • Received a total compensation of $3,672,605

Eric Benevich Trading

  • Largest purchase of shares was 20,595 units , worth over $741.21K on November 4, 2020
  • Largest sale of shares was 20,595 units , worth over $1.99M on November 4, 2020
  • In total has made about 18 transactions over 6 years
  • Usually trades in February, with the busiest year in 2020
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Eric Benevich Mailing Address

  • Mailing address is C/o Neurocrine Biosciences, Inc. 12790 el Camino Real San Diego CA 92130 CA

Neurocrine Biosciences Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Stock Awards
Other Compensation
Total
Kevin C. Gorman, Ph.D. 2018 $675,000 $425,250 $4,486,852 $2,998,832 $47,045 $8,632,979
Kevin C. Gorman, Ph.D. 2019 $725,000 $667,000 $6,000,525 $2,000,071 $58,230 $9,450,826
Kevin C. Gorman, Ph.D. 2020 $775,000 $542,500 $7,124,633 $5,375,188 $63,311 $13,880,632
Matthew C. Abernethy 2018 $420,000 $199,500 - $1,996,506 $69,741 $2,685,747
Matthew C. Abernethy 2019 $495,600 $284,970 $3,750,345 $1,250,035 $42,170 $5,823,120
Matthew C. Abernethy 2020 $545,200 $190,820 $2,999,869 $2,500,266 $45,021 $6,281,176
Eric Benevich 2018 $432,600 $205,485 $1,496,335 $1,499,417 $38,768 $3,672,605
Eric Benevich 2019 $467,200 $280,320 $3,750,345 $1,250,035 $45,547 $5,793,447
Eric Benevich 2020 $499,900 $199,960 $2,999,869 $3,000,257 $48,974 $6,748,960
Kyle W. Gano, Ph.D. 2018 $403,100 $191,473 $1,309,024 $2,656,575 $8,069 $4,568,241
Kyle W. Gano, Ph.D. 2019 $443,400 $266,040 $3,000,285 $1,000,076 $16,171 $4,725,972
Kyle W. Gano, Ph.D. 2020 $487,700 $207,273 $3,749,799 $2,750,210 $16,751 $7,211,733
Eiry W. Roberts, M.D. 2018 $490,700 $220,800 $2,863,700 $4,053,869 $671,554 $8,300,623
Eiry W. Roberts, M.D. 2019 $538,200 $309,465 $3,000,285 $1,000,076 $51,889 $4,899,915
Eiry W. Roberts, M.D. 2020 $575,900 $215,963 $2,624,855 $2,375,242 $56,073 $5,848,033
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/914475/000119312521111693/d87247ddef14a.htm

Neurocrine Biosciences Inc Insider Trading

  • The most recent transaction was 5,000 units sold on October 12, 2021 by Gary Lyons worth over $525.29K
  • In the last 18 years, insiders at Neurocrine Biosciences Inc sold an estimated value of $339.28M and bought an estimated value of $58.79M
  • The most active traders are Dimitri Grigoriadis, Chief Research Officer,  Haig Bozigian, Chief Development Officer,  and Gary Lyons, Director
  • Insider trading is most common in May, with the busiest year in 2017

NEUROCRINE BIOSCIENCES INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1